AI Article Synopsis
- A 41-year-old woman with relapsed acute myelogenous leukemia received treatment involving idarubicin and cytarabine.
- She experienced a 6-cm stricture in her lower esophagus 12 days after therapy, likely due to mucosal damage from the chemotherapy rather than her prior candida infection.
- This case highlights the importance of monitoring for esophageal strictures in patients facing swallowing issues following intensive chemotherapy.
Article Abstract
A 41-year-old woman with relapsed acute myelogenous leukemia was treated twice with idarubicin hydrochloride and cytarabine. She developed a 6-cm-long stricture in the lower esophagus 12 days after re-induction therapy. Although she had preceding candida infection, it is suspected that her stricture was caused by mucosal damage due to chemotherapeutic agents. This case suggests that the possibility of esophageal stricture should be considered in patients with swallowing disturbance after intensive chemotherapy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
myelogenous leukemia
8
esophageal stricture
8
[acute myelogenous
4
leukemia associated
4
associated severe
4
severe esophageal
4
stricture
4
stricture chemotherapy]
4
chemotherapy] 41-year-old
4
41-year-old woman
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!